PortfoliosLab logoPortfoliosLab logo
WRNA.DE vs. NBTK.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WRNA.DE vs. NBTK.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WRNA.DE achieves a 10.48% return, which is significantly higher than NBTK.DE's 4.27% return.


WRNA.DE

1D
4.08%
1M
4.18%
YTD
10.48%
6M
10.41%
1Y
48.70%
3Y*
0.92%
5Y*
10Y*

NBTK.DE

1D
2.92%
1M
1.60%
YTD
4.27%
6M
3.10%
1Y
38.65%
3Y*
9.94%
5Y*
5.63%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

WRNA.DE vs. NBTK.DE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WRNA.DE
WisdomTree BioRevolution UCITS ETF USD Acc
10.48%9.13%-10.92%-3.37%-22.01%-0.98%
NBTK.DE
Invesco Nasdaq Biotech UCITS ETF
4.27%18.60%4.57%2.51%-6.11%-0.20%

Correlation

The correlation between WRNA.DE and NBTK.DE is 0.81, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.81

Correlation (3Y)
Calculated over the trailing 3-year period

0.82

Correlation (All Time)
Calculated using the full available price history since Dec 10, 2021

0.84

The correlation between WRNA.DE and NBTK.DE has been stable across timeframes, ranging from 0.81 to 0.84 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WRNA.DE vs. NBTK.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WRNA.DE
WRNA.DE Risk / Return Rank: 5656
Overall Rank
WRNA.DE Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
WRNA.DE Sortino Ratio Rank: 5252
Sortino Ratio Rank
WRNA.DE Omega Ratio Rank: 4848
Omega Ratio Rank
WRNA.DE Calmar Ratio Rank: 7373
Calmar Ratio Rank
WRNA.DE Martin Ratio Rank: 5656
Martin Ratio Rank

NBTK.DE
NBTK.DE Risk / Return Rank: 7171
Overall Rank
NBTK.DE Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
NBTK.DE Sortino Ratio Rank: 6363
Sortino Ratio Rank
NBTK.DE Omega Ratio Rank: 5656
Omega Ratio Rank
NBTK.DE Calmar Ratio Rank: 9292
Calmar Ratio Rank
NBTK.DE Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WRNA.DE vs. NBTK.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WRNA.DENBTK.DEDifference
Sharpe ratioReturn per unit of total volatility

-0.28

Sortino ratioReturn per unit of downside risk

-0.40

Omega ratioGain probability vs. loss probability

1.30

1.34

-0.04

Calmar ratioReturn relative to maximum drawdown

3.61

6.16

-2.55

Martin ratioReturn relative to average drawdown

9.63

17.06

-7.43

WRNA.DE vs. NBTK.DE - Sharpe Ratio Comparison

The current WRNA.DE Sharpe Ratio is 1.75, which is comparable to the NBTK.DE Sharpe Ratio of 2.03. The chart below compares the historical Sharpe Ratios of WRNA.DE and NBTK.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


WRNA.DENBTK.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.75

2.03

-0.28

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.20

0.42

-0.61

Drawdowns

WRNA.DE vs. NBTK.DE - Drawdown Comparison

The maximum WRNA.DE drawdown since its inception was -52.35%, which is greater than NBTK.DE's maximum drawdown of -30.99%. Use the drawdown chart below to compare losses from any high point for WRNA.DE and NBTK.DE.


Loading charts...

Drawdown Indicators


WRNA.DENBTK.DEDifference

Max Drawdown

Largest peak-to-trough decline

-52.35%

-30.99%

-21.36%

Max Drawdown (1Y)

Largest decline over 1 year

-13.42%

-6.24%

-7.18%

Max Drawdown (3Y)

Largest decline over 3 years

-40.06%

-29.35%

-10.71%

Max Drawdown (5Y)

Largest decline over 5 years

-30.99%

Current Drawdown

Current decline from peak

-20.73%

-1.44%

-19.29%

Average Drawdown

Average peak-to-trough decline

-27.26%

-10.62%

-16.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.04%

2.26%

+2.78%

Volatility

WRNA.DE vs. NBTK.DE - Volatility Comparison

WisdomTree BioRevolution UCITS ETF USD Acc (WRNA.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) have volatilities of 6.73% and 6.41%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WRNA.DENBTK.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.73%

6.41%

+0.32%

Volatility (6M)

Calculated over the trailing 6-month period

17.21%

14.11%

+3.10%

Volatility (1Y)

Calculated over the trailing 1-year period

27.70%

19.00%

+8.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.22%

20.30%

+3.92%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.22%

22.05%

+2.17%

WRNA.DE vs. NBTK.DE - Expense Ratio Comparison

WRNA.DE has a 0.45% expense ratio, which is higher than NBTK.DE's 0.40% expense ratio.


Dividends

WRNA.DE vs. NBTK.DE - Dividend Comparison

Neither WRNA.DE nor NBTK.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


WRNA.DE and NBTK.DE have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, NBTK.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.

NBTK.DE is cheaper with a 0.40% expense ratio, compared with 0.45% for WRNA.DE.

WRNA.DE tracks WisdomTree BioRevolution ESG Screened, while NBTK.DE tracks Nasdaq Biotechnology. They also come from different issuers: WisdomTree and Invesco. Their fees differ too: 0.45% for WRNA.DE and 0.40% for NBTK.DE.

Portfolio Optimizer

Find the right allocation for WRNA.DE and NBTK.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer